Overview of Zooki’s NAD+ Supplement
Zooki has launched a new supplement featuring 300mg of NAD+ (Nicotinamide adenine dinucleotide) per serving, designed for optimal absorption in the small intestine. This innovative product utilizes liposomal encapsulation, providing a shield for the NAD+ molecule against the harsh environment of the stomach, allowing for better delivery and absorption.
Key Highlights:
-
Liposomal Encapsulation:
- NAD+ is carried within liposomes—tiny spheres made of phospholipids that mimic cell membranes.
- This process protects NAD+ and helps it reach the small intestine, where absorption occurs.
-
Clean Ingredients:
- The formulation is free from dairy and soy, making it suitable for vegans.
- Aimed at consumers looking for a more approachable option in the cellular health category.
-
Consumer Appeal:
- Targets individuals interested in healthy aging who may find current products too clinical or technical.
- Simplifies scientific concepts for better consumer understanding.
-
Market Positioning:
- Founded in 2016, Zooki has established itself with liposomal products such as vitamins and collagen.
- The NAD+ formulation marks its first venture into cellular health, responding to growing consumer interest in longevity.
-
Future of Cellular Health:
- Carolides expresses confidence that the focus on cellular health will expand within the brand’s offerings.
- The new product complements existing products like glutathione and hyaluronic acid.
-
Importance of NAD+:
- NAD+ is crucial for cellular energy production, DNA repair, and metabolic processes.
- It naturally declines with age, making supplementation attractive for those looking to combat aging effects.
The product not only aims to satisfy curiosity around NAD+ but also integrates seamlessly into existing health routines with its complementary benefits. As the market for longevity continues to grow, Zooki is positioning itself as a key player with this innovative formulation.